Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
172 hedge funds and large institutions have $683M invested in Natus Medical Inc in 2020 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 66 increasing their positions, 56 reducing their positions, and 21 closing their positions.
134% more call options, than puts
Call options by funds: $3M | Put options by funds: $1.28M
33% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 21
18% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 56
4% more funds holding
Funds holding: 166 → 172 (+6)
7% less capital invested
Capital invested by funds: $735M → $683M (-$52.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$15.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$8.84M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
+$8.81M |
| 4 |
BlackRock
New York
|
+$7.47M |
| 5 |
Renaissance Technologies
New York
|
+$6.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$27.3M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
-$26M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$20.5M |
| 4 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$8.52M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.86M |
NTUS Hedge Fund Activity: Q2 2020 in Review
172 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2020, worth a combined $683M — down 7.1% from $735M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new NTUS positions and 21 closed out — a net gain of 7 holders — while 66 added to existing stakes and 56 trimmed.
The largest buyer was Wells Fargo, adding an estimated $15.5M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $27.3M sold.
- 172 institutional investors held Natus Medical Inc (NTUS) as of Q2 2020, up from 166 in Q1 2020.
- Funds reported $683M of Natus Medical Inc stock for Q2 2020, down 7.1% quarter-over-quarter.
- 28 funds opened new Natus Medical Inc positions in Q2 2020 and 21 closed out, a net change of +7 holders.
- The largest Natus Medical Inc buyer in Q2 2020 was Wells Fargo, an estimated $15.5M added.
- The largest Natus Medical Inc seller in Q2 2020 was Janus Henderson Group, an estimated $27.3M sold.
Based on aggregated 13F filings for Q2 2020.